| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advancing diversity: the role of international medical graduates
|
David, Yakira N
|
|
|
6 |
12 |
p. 980-981
|
artikel
|
| 2 |
Alcohol-related cirrhosis and liver cancer: a call for inclusion in non-communicable disease action plans
|
Bhadoria, Ajeet Singh
|
|
|
6 |
12 |
p. 982
|
artikel
|
| 3 |
Artificial intelligence in colonoscopy
|
Soffer, Shelly
|
|
|
6 |
12 |
p. 984
|
artikel
|
| 4 |
Artificial intelligence in colonoscopy
|
Murakami, Daisuke
|
|
|
6 |
12 |
p. 984-985
|
artikel
|
| 5 |
A step towards informed positioning of advanced therapies for moderate-to-severe Crohn's disease
|
Ahmed, Waseem
|
|
|
6 |
12 |
p. 973-975
|
artikel
|
| 6 |
Bariatric surgery and prophylaxis against symptomatic gallstone disease
|
Welbourn, Richard
|
|
|
6 |
12 |
p. 972-973
|
artikel
|
| 7 |
Combining systemic and local therapies for hepatocellular carcinoma
|
Wehrenberg-Klee, Eric
|
|
|
6 |
12 |
p. 976-978
|
artikel
|
| 8 |
Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis
|
Singh, Siddharth
|
|
|
6 |
12 |
p. 1002-1014
|
artikel
|
| 9 |
Correction to Lancet Gastroenterol Hepatol 2021; 6: 781
|
|
|
|
6 |
12 |
p. e8
|
artikel
|
| 10 |
Correction to Lancet Gastroenterol Hepatol 2021; 6: 875
|
|
|
|
6 |
12 |
p. e8
|
artikel
|
| 11 |
Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia): a randomised, multicentre, double-blind, phase 3 trial
|
Xu, Rui-Hua
|
|
|
6 |
12 |
p. 1015-1024
|
artikel
|
| 12 |
Epidemiology, risk factors, social determinants of health, and current management for non-alcoholic fatty liver disease in sub-Saharan Africa
|
Spearman, C Wendy
|
|
|
6 |
12 |
p. 1036-1046
|
artikel
|
| 13 |
Features of gastrointestinal amyloidosis
|
Hokama, Akira
|
|
|
6 |
12 |
p. 987
|
artikel
|
| 14 |
Features of gastrointestinal amyloidosis – Authors’ reply
|
Latorre, Gonzalo
|
|
|
6 |
12 |
p. 987
|
artikel
|
| 15 |
Health-care provision and policy for non-alcoholic fatty liver disease in sub-Saharan Africa
|
Spearman, C Wendy
|
|
|
6 |
12 |
p. 1047-1056
|
artikel
|
| 16 |
Metabolic-associated fatty liver disease in children and adolescents: Mexican experience
|
Méndez-Sánchez, Nahum
|
|
|
6 |
12 |
p. 986
|
artikel
|
| 17 |
Metabolic dysfunction-associated fatty liver disease and insulin resistance in type 1 diabetes
|
Snaith, Jennifer R
|
|
|
6 |
12 |
p. 985-986
|
artikel
|
| 18 |
Plant-based diets in gastrointestinal disorders: something, nothing, or everything?
|
So, Daniel
|
|
|
6 |
12 |
p. 992
|
artikel
|
| 19 |
Public health funding in England: death by a thousand cuts
|
The Lancet Gastroenterology & Hepatology,
|
|
|
6 |
12 |
p. 971
|
artikel
|
| 20 |
Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trial
|
Tai, David
|
|
|
6 |
12 |
p. 1025-1035
|
artikel
|
| 21 |
Ramucirumab plus paclitaxel for gastric cancer in China
|
Yoon, Harry H
|
|
|
6 |
12 |
p. 975-976
|
artikel
|
| 22 |
Research in Brief
|
Baker, Holly
|
|
|
6 |
12 |
p. 991
|
artikel
|
| 23 |
SARS-CoV-2 vaccination uptake by patients with inflammatory bowel disease on biological therapy
|
Selim, Rania
|
|
|
6 |
12 |
p. 989
|
artikel
|
| 24 |
Spore-forming probiotics for functional dyspepsia
|
Mullie, Patrick
|
|
|
6 |
12 |
p. 982-983
|
artikel
|
| 25 |
Spore-forming probiotics for functional dyspepsia – Authors’ reply
|
Wauters, Lucas
|
|
|
6 |
12 |
p. 983-984
|
artikel
|
| 26 |
The under-recognised effects of serious endoscopic complications on practitioners
|
Berry, Philip
|
|
|
6 |
12 |
p. 978-980
|
artikel
|
| 27 |
Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease
|
Alexander, James L
|
|
|
6 |
12 |
p. 987-988
|
artikel
|
| 28 |
UEG Week Virtual 2021
|
Thomas, Hugh
|
|
|
6 |
12 |
p. 990
|
artikel
|
| 29 |
Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial
|
Haal, Sylke
|
|
|
6 |
12 |
p. 993-1001
|
artikel
|
Tijdschrift beschrijving